Friday, May 22, 2015

Caffeine intake associated with reduced levels of erectile dysfunction

Posted: 19 May 2015 11:00 PM PDT
Men who drink the equivalent caffeine level of two to three cups of coffee a day are less likely to have erectile dysfunction (ED), according to researchers from The University of Texas Health Science Center at Houston (UTHealth). The results of a study published recently in PLOS ONE found that men who consumed between 85 and 170 milligrams of caffeine a day were 42 percent less likely to report ED,

Tuesday, May 5, 2015

Scientists find new link between diabetes and Alzheimer's

Posted: 05 May 2015 12:00 AM PDT
Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.

Thursday, April 23, 2015

United States first country to launch Saxenda®

Posted: 22 Apr 2015 05:00 AM PDT
Novo Nordisk today announced that Saxenda® (liraglutide 3 mg) is now available in the United States (US). Saxenda® is the first glucagon-like peptide-1 (GLP-1) receptor agonist for weight management, approved in the US, EU and Canada.

Wednesday, April 1, 2015

Researchers question use of paracetamol for lower back pain and osteoarthritis

Posted: 01 Apr 2015 02:00 AM PDT
New research shows that paracetamol is ineffective in reducing pain, disability or improving quality of life for patients who suffer from low back pain or osteoarthritis of the hip or knee, and its use may affect the liver. The study published in the British Medical Journal provides new evidence that paracetamol is no better at treating low back pain than a placebo and its effect on osteoarthritis of the hip or knee is too small to be clinically worthwhile.

Wednesday, March 11, 2015

Hormone replacement therapy for postmenopausal women: Does it help or harm your heart?

Posted: 10 Mar 2015 02:00 AM PDT
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke. HRT, now more commonly known as hormone therapy, is widely used for controlling menopausal symptoms. It has also been used for the prevention of cardiovascular disease in post-menopausal women.

Monday, February 23, 2015

Safety and life-saving efficacy of statins have been exaggerated

Posted: 23 Feb 2015 04:00 AM PST
Hailed as miracle drugs when they hit the market two decades ago, statins, the cholesterol-lowering drugs prescribed to prevent heart attacks, are not as effective nor as safe as we have been led to believe, say Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and an expert in cholesterol and cardiovascular disease.

Saturday, February 14, 2015

Short-term use of hormone replacement therapy associated with increased ovarian cancer risk

Posted: 12 Feb 2015 11:00 PM PST
Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet.